Anne Samuel

Stock Analyst at JP Morgan

(2.51)
# 2,408
Out of 4,996 analysts
70
Total ratings
51.16%
Success rate
1.46%
Average return

Stocks Rated by Anne Samuel

HealthEquity
Sep 3, 2025
Maintains: Overweight
Price Target: $125$126
Current: $96.53
Upside: +30.53%
Veeva Systems
Aug 28, 2025
Maintains: Neutral
Price Target: $274$290
Current: $290.27
Upside: -0.09%
Progyny
Aug 26, 2025
Maintains: Neutral
Price Target: $23$25
Current: $21.46
Upside: +16.50%
Doximity
May 27, 2025
Maintains: Neutral
Price Target: $63$60
Current: $74.40
Upside: -19.35%
IQVIA Holdings
May 19, 2025
Maintains: Overweight
Price Target: $232$177
Current: $179.56
Upside: -1.43%
Omnicell
Mar 20, 2025
Maintains: Neutral
Price Target: $44$36
Current: $30.72
Upside: +17.19%
Evolent Health
Mar 10, 2025
Maintains: Overweight
Price Target: $13$12
Current: $8.95
Upside: +34.08%
Phreesia
Sep 9, 2024
Maintains: Overweight
Price Target: $27$28
Current: $23.62
Upside: +18.54%
Premier
Sep 9, 2024
Maintains: Neutral
Price Target: $21$19
Current: $27.81
Upside: -31.68%
Consensus Cloud Solutions
Sep 9, 2024
Downgrades: Underweight
Price Target: $19$21
Current: $29.39
Upside: -28.55%
Maintains: Overweight
Price Target: $10$13
Current: $2.80
Upside: +364.29%
Maintains: Overweight
Price Target: $24$27
Current: $37.56
Upside: -28.12%
Downgrades: Underweight
Price Target: $7$5
Current: $3.98
Upside: +25.63%